These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 17453949)

  • 1. The effect of methylprednisolone pulse treatment on cytokine network in Graves ophthalmopathy.
    Lacka K; Manuszewska E; Korczowska I; Lacki JK
    Curr Eye Res; 2007 Mar; 32(3):291-7. PubMed ID: 17453949
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Serum Th1 and Th2 profile cytokine level changes in patients with Graves' ophthalmopathy treated with corticosteroids.
    Myśliwiec J; Kretowski A; Topolska J; Siewko K; Jakubczyk D; Szelachowska M; Mikita A; Kinalska I
    Horm Metab Res; 2001 Dec; 33(12):739-43. PubMed ID: 11753760
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Treatment of Grave's ophthalmopathy with high doses of corticosteroids].
    Cirić J; Zarković M; Stojanović M; Pepenezić Z; Randjelović G; Gligorović M; Trbojević B; Drezgić M; Nesović M
    Srp Arh Celok Lek; 2000; 128(5-6):179-83. PubMed ID: 11089418
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The application of temperature measurement of the eyes by digital infrared thermal imaging as a prognostic factor of methylprednisolone pulse therapy for Graves' ophthalmopathy.
    Shih SR; Li HY; Hsiao YL; Chang TC
    Acta Ophthalmol; 2010 Aug; 88(5):e154-9. PubMed ID: 20553230
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical results of anti-inflammatory therapy in Graves' ophthalmopathy and association with thyroidal autoantibodies.
    Eckstein AK; Plicht M; Lax H; Hirche H; Quadbeck B; Mann K; Steuhl KP; Esser J; Morgenthaler NG
    Clin Endocrinol (Oxf); 2004 Nov; 61(5):612-8. PubMed ID: 15521965
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Serum IL-1 receptor antagonist and IL-1beta in patients with Graves' opthalmopathy].
    Xie Q; Li SQ; Aa ZM; Wei SQ; Zhao HL
    Sichuan Da Xue Xue Bao Yi Xue Ban; 2006 Mar; 37(2):238-41. PubMed ID: 16608084
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Serum pro- and anti-inflammatory cytokines in patients with Graves' disease with ophthalmopathy during treatment with glucocorticoids.
    Myśliwiec J; Kretowski A; Szelachowska M; Mikita A; Kinalska I
    Rocz Akad Med Bialymst; 1999; 44():160-9. PubMed ID: 10697431
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Serum concentrations of HGF and IL-8 in patients with active Graves' orbitopathy before and after methylprednisolone therapy.
    Nowak M; Siemińska L; Karpe J; Marek B; Kos-Kudła B; Kajdaniuk D
    J Endocrinol Invest; 2016 Jan; 39(1):63-72. PubMed ID: 26062519
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of intravenous methylprednisolone therapy vs. oral methylprednisolone therapy in patients with Graves' ophthalmopathy.
    Aktaran S; Akarsu E; Erbağci I; Araz M; Okumuş S; Kartal M
    Int J Clin Pract; 2007 Jan; 61(1):45-51. PubMed ID: 16889639
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Methylprednisolone and hepatotoxicity in Graves' ophthalmopathy.
    Wichary H; Gasińska T
    Thyroid; 2012 Jan; 22(1):64-9. PubMed ID: 22029719
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The balance shift in Th1/Th2 related IL-12/IL-5 cytokines in Graves' disease during methimazole therapy.
    Molnár I
    Autoimmunity; 2007 Feb; 40(1):31-7. PubMed ID: 17364495
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of pulse methylprednisolone and oral methylprednisolone treatments on serum levels of oxidative stress markers in Graves' ophthalmopathy.
    Akarsu E; Buyukhatipoglu H; Aktaran S; Kurtul N
    Clin Endocrinol (Oxf); 2011 Jan; 74(1):118-24. PubMed ID: 21044110
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Serum IL-18 levels are not increased in patients with untreated Graves' ophthalmopathy.
    Wakelkamp IM; Prummel MF; Wiersinga WM
    Horm Metab Res; 2004 Jan; 36(1):44-7. PubMed ID: 14983406
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Thyrotropin receptor antibodies detected by the human recombinant TBII assay--a surrogate marker for autoimmune activity in Graves' ophthalmopathy?
    Myśliwiec J; Kretowski A; Stepień A; Mirończuk K; Kinalska I
    Med Sci Monit; 2002 Sep; 8(9):MT159-62. PubMed ID: 12218953
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Association between Clinical Activity Score and Serum Interleukin-6, Interleukin-8 and Interleukin-10 during Systemic Glucocorticoid Treatment for Active Moderate-to-Severe Graves' Orbitopathy.
    Stoynova MA; Shinkov AD; Georgiev GK; Kovatcheva RD
    Curr Eye Res; 2021 Oct; 46(10):1503-1508. PubMed ID: 33849364
    [No Abstract]   [Full Text] [Related]  

  • 16. Soluble CD40 and its ligand CD154 in patients with Graves' ophthalmopathy during combined therapy with corticosteroids and teleradiotherapy.
    Myśliwiec J; Waligórski D; Nikołajuk A; Górska M
    Adv Med Sci; 2007; 52():104-8. PubMed ID: 18217399
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The effect of etanercept on Graves' ophthalmopathy: a pilot study.
    Paridaens D; van den Bosch WA; van der Loos TL; Krenning EP; van Hagen PM
    Eye (Lond); 2005 Dec; 19(12):1286-9. PubMed ID: 15550932
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The influence of radioiodine therapy on ocular changes and their relation to urine cotinine level in patients with Graves' Ophthalmopathy.
    Czarnywojtek A; Zgorzalewicz-Stachowiak M; Budny B; Wasko R; Florek E; Szczepanek E; Komar-Rychlicka K; Waligorska-Stachura J; Kurdybacha P; Miechowicz I; Ruchala M
    Neuro Endocrinol Lett; 2013; 34(3):241-8. PubMed ID: 23685424
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pulsatile ocular blood flow change after treatment with systemic steroid in patients with Graves' ophthalmopathy.
    Tsai CC; Kau HC; Tsai HH; Kao SC; Hsu WM
    Eye (Lond); 2006 Sep; 20(9):1025-9. PubMed ID: 16123781
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Surgical or medical decompression as a first-line treatment of optic neuropathy in Graves' ophthalmopathy? A randomized controlled trial.
    Wakelkamp IM; Baldeschi L; Saeed P; Mourits MP; Prummel MF; Wiersinga WM
    Clin Endocrinol (Oxf); 2005 Sep; 63(3):323-8. PubMed ID: 16117821
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.